THE CHEMICAL BASIS OF THE VIRULENCE OF BACILLUS ANTHRACIS. IX. ITS AGGRESSINS AND THEIR MODE OF ACTION.
作者信息
KEPPIE J, HARRIS-SMITH P W, SMITH H
出版信息
Br J Exp Pathol. 1963 Aug;44(4):446-53.
Abstract
摘要
相似文献
1
THE CHEMICAL BASIS OF THE VIRULENCE OF BACILLUS ANTHRACIS. IX. ITS AGGRESSINS AND THEIR MODE OF ACTION.炭疽杆菌毒力的化学基础。IX. 其侵袭素及其作用方式。
Br J Exp Pathol. 1963 Aug;44(4):446-53.
2
STUDIES ON ANTHRAX INFECTIONS IN IMMUNIZED GUINEA PIGS.免疫豚鼠炭疽感染的研究。
J Infect Dis. 1965 Feb;115:59-67. doi: 10.1093/infdis/115.1.59.
3
THE BIOLOGIC ACTIVITIES OF BACILLUS ANTHRACIS AND BACILLUS CEREUS CULTURE FILTRATES.炭疽芽孢杆菌和蜡样芽孢杆菌培养滤液的生物活性
Am J Pathol. 1963 Aug;43(2):201-11.
4
[CHEMICAL BASES FOR THE VIRULENCE AND PATHOGENICITY OF MICROORGANISMS].[微生物毒力和致病性的化学基础]
Usp Sovrem Biol. 1964 Jul-Aug;58:74-85.
5
ALTERATIONS IN THE BIOLOGICAL ACTIVITY OF PROTECTIVE ANTIGEN OF BACILLUS ANTHRACIS TOXIN.炭疽杆菌毒素保护性抗原生物活性的改变
Proc Soc Exp Biol Med. 1963 Nov;114:294-7.
6
METABOLISM OF MICROORGANISMS AS RELATED TO THEIR PATHOGENICITY.与微生物致病性相关的微生物代谢
Annu Rev Microbiol. 1963;17:297-328. doi: 10.1146/annurev.mi.17.100163.001501.
7
INDUCIBLE LYTIC SYSTEMS IN THE GENUS BACILLUS.芽孢杆菌属中的诱导性裂解系统
J Gen Microbiol. 1965 Apr;39:53-62. doi: 10.1099/00221287-39-1-53.
8
Toxin production as a criterion for differentiating Bacillus cereus and Bacillus anthracis.毒素产生作为区分蜡样芽孢杆菌和炭疽芽孢杆菌的标准。
J Bacteriol. 1963 Feb;85(2):490-1. doi: 10.1128/jb.85.2.490-491.1963.
9
DECONTAMINATION OF CLASS III HOOD OR ANIMAL HOLDING SYSTEM WITH FORMALDEHYDE.使用甲醛对III级生物安全柜或动物饲养系统进行去污处理。
Tech Man US Army Biol Lab. 1963 Apr;86:1-11.
10
Purification of factor I and recognition of a third factor of the anthrax toxin.炭疽毒素因子I的纯化及第三种炭疽毒素因子的鉴定
J Gen Microbiol. 1961 Sep;26:49-63. doi: 10.1099/00221287-26-1-49.
引用本文的文献
1
CDC Guidelines for the Prevention and Treatment of Anthrax, 2023.2023 年美国疾病预防控制中心炭疽病预防和治疗指南。
MMWR Recomm Rep. 2023 Nov 17;72(6):1-47. doi: 10.15585/mmwr.rr7206a1.
2
The capsule of Bacillus anthracis protects it from the bactericidal activity of human defensins and other cationic antimicrobial peptides.炭疽杆菌的荚膜使其免受人防御素和其他阳离子抗菌肽的杀菌活性影响。
PLoS Pathog. 2022 Sep 29;18(9):e1010851. doi: 10.1371/journal.ppat.1010851. eCollection 2022 Sep.
3
What Is Anthrax?什么是炭疽？
Pathogens. 2022 Jun 16;11(6):690. doi: 10.3390/pathogens11060690.
4
Human Innate Immune Cells Respond Differentially to Poly-γ-Glutamic Acid Polymers from and Nonpathogenic Species.人先天免疫细胞对 及非致病 物种的多聚-γ-谷氨酸聚合物的反应不同。
J Immunol. 2020 Mar 1;204(5):1263-1273. doi: 10.4049/jimmunol.1901066. Epub 2020 Jan 13.
5
Development and application of a Bacillus anthracis protective antigen domain-1 in-house ELISA for the detection of anti-protective antigen antibodies in cattle in Zambia.建立并应用炭疽芽孢杆菌保护性抗原结构域 1 酶联免疫吸附试验检测赞比亚牛抗保护性抗原抗体。
PLoS One. 2018 Oct 18;13(10):e0205986. doi: 10.1371/journal.pone.0205986. eCollection 2018.
6
Use of Canonical Single Nucleotide Polymorphism (CanSNPs) to characterize outbreak strains in Zambia between 1990 and 2014.使用标准单核苷酸多态性（CanSNPs）对1990年至2014年赞比亚的疫情菌株进行特征分析。
PeerJ. 2018 Jul 26;6:e5270. doi: 10.7717/peerj.5270. eCollection 2018.
7
The Pseudomonas aeruginosa Exoenzyme Y: A Promiscuous Nucleotidyl Cyclase Edema Factor and Virulence Determinant.铜绿假单胞菌外毒素Y：一种多功能核苷酸环化酶水肿因子和毒力决定因素。
Handb Exp Pharmacol. 2017;238:67-85. doi: 10.1007/164_2016_5003.
8
Exposure to Bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cells.接触炭疽芽孢杆菌荚膜会导致人单核细胞衍生的树突状细胞受到抑制。
Infect Immun. 2014 Aug;82(8):3405-16. doi: 10.1128/IAI.01857-14. Epub 2014 Jun 2.
9
Microbial production and chemical transformation of poly-γ-glutamate.聚γ-谷氨酸的微生物生产和化学转化。
Microb Biotechnol. 2013 Nov;6(6):664-74. doi: 10.1111/1751-7915.12072. Epub 2013 Jul 15.
10
Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule.人源化抗炭疽芽胞杆菌荚膜单克隆抗体对小鼠致死性炭疽感染的预防和暴露后保护作用。
Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):739-44. doi: 10.1073/pnas.1017677108. Epub 2010 Dec 27.
本文引用的文献
1
The serological relationship between purified preparations of factors I and II of the anthrax toxin produced in vivo and in vitro.体内和体外产生的炭疽毒素I因子和II因子纯化制剂之间的血清学关系。
J Gen Microbiol. 1960 Feb;22:219-28. doi: 10.1099/00221287-22-1-219.
2
Purification of the third factor of anthrax toxin.炭疽毒素第三因子的纯化
J Gen Microbiol. 1962 Nov;29:517-21. doi: 10.1099/00221287-29-3-517.
3
Purification of factors I and II of the anthrax toxin produced in vivo.体内产生的炭疽毒素I因子和II因子的纯化。
J Gen Microbiol. 1960 Feb;22:206-18. doi: 10.1099/00221287-22-1-206.
4
5
6
Polyglutamic acid from Bacillus anthracis grown in vivo; structure and aggressin activity.体内培养的炭疽芽孢杆菌产生的聚谷氨酸；结构与侵袭素活性
Biochem J. 1956 Jul;63(3):437-42. doi: 10.1042/bj0630437.
7
The chemical basis of the virulence of bacillus anthracis. II. Some biological properties of bacterial products.炭疽杆菌毒力的化学基础。II. 细菌产物的一些生物学特性。
Br J Exp Pathol. 1953 Oct;34(5):486-96.
Zotero 插件